InsiderTrades

Form 4 for ALAB Astera Labs, Inc.

Accepted 2024-03-22 00:00:00 ET · period of report 2024-03-20 · accession 0000950170-24-035418 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-03-22 2024-03-20 ALAB Tate Michael Truett CFO F - Tax $36.00 -28.7K 1.27M -2% -$1.03M
DI 2024-03-22 2024-03-22 ALAB Tate Michael Truett CFO C - Cnv Deriv — +879.1K 2.15M +69% —
DI 2024-03-22 2024-03-22 ALAB Tate Michael Truett CFO C - Cnv Deriv $0.00 -879.1K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-03-20 F D 28,689 $36.00 1,271,380 D By Tate Trust — — (F1) Represents shares of Common Stock withheld by the Issuer in satisfaction of tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. Such withholding is mandated by an election of the Issuer made in advance and does not represent a discretionary trade by the Reporting Person. (F3) These shares are owned directly by Michael T Tate and Jeanne Larue Tate as Trustees of the Tate 1997 Living Trust Dated April 24, 1997 (the "Tate Trust"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
2 Common Common Stock 2024-03-22 C A 879,108 — 2,150,488 I — — (F2) Each share of Series A Preferred Stock automatically converted into one share of Common Stock on a one-for-one basis, immediately prior to the closing of the Issuer's initial public offering. The shares of Series A Preferred Stock have no expiration date.
3 Derivative Series A Preferred 2024-03-22 C D 879,108 $0.00 0 I By Tate Trust — · — to — 879,108 Common Stock (F3) These shares are owned directly by Michael T Tate and Jeanne Larue Tate as Trustees of the Tate 1997 Living Trust Dated April 24, 1997 (the "Tate Trust"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. (F2) Each share of Series A Preferred Stock automatically converted into one share of Common Stock on a one-for-one basis, immediately prior to the closing of the Issuer's initial public offering. The shares of Series A Preferred Stock have no expiration date.